Summit Therapeutics Inc. - COM (SMMT)

CUSIP: 86627T108

Q3 2025 13F Holders as of 30 Sep 2025

Security identity
Holder snapshot
Share change
+5,045,728
Put/Call ratio
85%
Reported price per share
$20.66
Number of holders
230
Value change
+$101,213,528
Number of buys
127
Number of sells
109

Security key

86627T108

Report period

Q3 2025

Institutions

230

Top holders

10

Ownership snapshot

Top reported holders of SMMT - Summit Therapeutics Inc. - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
BAKER BROS. ADVISORS LP
13D/G signal
Evidence rows
15
Latest as of
30 Jun 2025
13F Highest disclosed value: $717,624,887 Showing 1-6 of 15 holder rows.

Rank 2 holder

FMR LLC

13F
Ownership
Position
$196.34M
13F
Holder Evidence Ownership % Position 12M Net Δ As of
BAKER BROS. ADVISORS LP
13F
Company
13F
class O/S missing
$717,624,887
33,722,974 shares
30 Jun 2025
FMR LLC
13F
Company
13F
class O/S missing
$196,337,286
9,226,376 shares
30 Jun 2025
VANGUARD GROUP INC
13F
Company
13F
class O/S missing
$184,575,740
8,673,672 shares
30 Jun 2025
BlackRock, Inc.
13F
Company
13F
class O/S missing
$145,697,074
6,846,667 shares
30 Jun 2025
STATE STREET CORP
13F
Company
13F
class O/S missing
$85,496,592
4,017,697 shares
30 Jun 2025
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
13F
class O/S missing
$83,103,000
3,905,148 shares
30 Jun 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
230
Shares
102,790,902
Rows available
230
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders
225
Q3 2025 holders
230
Holder diff
5
Investor Q2 2025 Shares Q3 2025 Shares Share Diff Share Chg % Q2 2025 value Q3 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .